Stay updated on Psilocybin Adjunct for Treatment-Resistant Depression Clinical Trial

Sign up to get notified when there's something new on the Psilocybin Adjunct for Treatment-Resistant Depression Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Psilocybin Adjunct for Treatment-Resistant Depression Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The record describes a completed Phase 2 study of psilocybin as an adjunctive therapy for treatment-resistant depression, including participant eligibility, study design, and outcome measures. It also provides study locations, investigator details, and downloadable protocol and analysis documents.
    Difference
    45%
    Check dated 2026-11-08T15:24:33.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now identifies the site as revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-11-01T16:30:32.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A banner announces that NIH websites are transitioning from the term “Artificial Intelligence” to “Super Intelligence.” It appears above the page’s 403 error message.
    Difference
    1%
    Check dated 2026-10-25T19:17:10.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2 while the page continued to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T22:35:30.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T22:40:39.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The study record page now displays a 403 Forbidden error, replacing the usual study details with an access-denied screen.
    Difference
    18%
    Check dated 2026-09-20T22:31:12.000Z thumbnail image

Stay in the know with updates to Psilocybin Adjunct for Treatment-Resistant Depression Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Psilocybin Adjunct for Treatment-Resistant Depression Clinical Trial page.